Fig. 3From: Diagnostic and therapeutic recommendations for the treatment of hyperphenylalaninemia in patients 0–4 years of ageCase studies to show response during the test phase in eight BH4-responsive patients. BH4: Tetrahydrobiopterin; Phe: Phenylalanine. P1–8, patients 1–8Back to article page